Safety study of inhaled ICF004 in healthy adults
Part of Lungs & breathing clinical trials.
This trial tests an inhaled medication called ICF004 in healthy adults to see if it is safe and how the body processes it. It may help in developing a new treatment for lung conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are in good health with no significant medical conditions.
- Your body mass index is between 18 and 28, and you meet the weight requirements.
- You have not smoked in the last 6 months.
- You are able to use an inhaler correctly and agree to use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new inhaled dry powder medicine (called ICF001) in healthy volunteers to see how safe it is and what side effects it might cause. It is a first-in-human study, so participants will help researchers understand the drug's effects and how it moves through the body.
This trial tests a single inhaled dose of RJ026 in patients with interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF) or connective tissue disease-related ILD (CTD-ILD). It helps see how the drug moves through the body and if it's safe.
This trial tests an investigational drug called NCR101 to see if it is safe and helps people with interstitial lung disease (a group of conditions that cause lung scarring and breathing problems). It may be an option if your lung disease has been stable and you are already on certain treatments.
This early-phase study tests an inhaled medication (CHF10136) to see if it's safe and how the body handles it. It includes both healthy adults and people with asthma, and participants will be monitored closely throughout.
This study tests a new inhaled powder (RC010) to see if it is safe and how the body processes it. It is for healthy adults who do not smoke and have no major health problems.
This trial tests a new inhaler medication to see if it is safe and how the body processes it. It may help in future treatments for lung conditions.
Hear when a new Interstitial Lung Disease (ILD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.